INO Earnings

Quarterly EPS
$-0.89
Q3 2024
$-0.65
Q4 2024
$-0.51
Q1 2025
$-0.61
Q2 2025
$-0.87
Q3 2025
$0.06
Q4 2025
$-0.28
Q1 2026
$-0.07
Q2 2026
Latest RevenueN/A
Latest Net Income-6012458
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.070-6012458+88.5%
Q1 2026-$0.280-19682798-100.0%+45.1%
Q4 2025$0.0603.8M-100.0%+109.2%
Q3 2025-$0.870-45496672+2.2%
Q2 2025-$0.610-23519412-100.0%+48.7%
Q1 2025-$0.5165.3K-19694697+61.1%
Q4 2024-$0.65117.0K-19381679+14.0%+40.9%
Q3 2024-$0.890-25165478-100.0%+41.4%
Q2 2024-$1.19100.8K-32237098
Q1 2024-$1.310-30469871
Q4 2023-$1.10102.7K-25003638
Q3 2023-$1.52388.4K-33929864
Inovio Pharmaceuticals (INO) — Earnings